Consistent with this, a decrease in IGF-1 signaling has been related with neurodegeneration, depressive disorders and other brain diseases, in which IGF-1 has been suggested as a possible therapy (Torres Aleman, 2012; Guan et al., 2013). This evidence concerns the gene IGF1 and depressive disorder.